Here are five highlights:
1. Direct sales were $43.6 million, a 10 percent increase compared to the second quarter of 2016.
2. Double digit growth was reported in RTI Surgical’s spine, surgical specialties and cardiothoracic direct business segments.
3. Commercial revenues were $28.6 million, a 2 percent increase compared to second quarter of 2016 results.
4. RTI Surgical’s adjusted earnings were $8.3 million or 11 percent of second quarter revenues.
5. From these results, RTI Surgical expects full year revenues to be between $274 million and $280 million.
More articles on devices and implants:
DePuy Synthes & Medical Enterprises Distribution to co-market automated THA technology: 6 points
Bioventus names new CFO, general counsel: 4 takeaways
Mazor Robotics, K2M, Globus Medical & more: 12 device company notes
